论文部分内容阅读
目的探讨nm23基因表达在人肺癌中的作用。方法通过Northern印迹杂交,检测40例人肺癌组织和19例非癌肺组织的nm23H1和nm23H2mRNA表达,采用地高辛标记和检测系统显示杂交信号,并分析mRNA表达与肺癌临床特征的关系。结果低分化鳞癌的nm23H2mRNA表达较中高分化鳞癌显著降低(P<0.01),小细胞肺癌的nm23H1和nm23H2mRNA表达较肺鳞癌明显降低。但在有或无淋巴结转移的原发癌灶组织间,以及肺癌的临床分期间,nm23基因mRNA表达差异无显著性(P>0.05)。结论nm23基因mRNA表达与肺癌的组织分化有关,未发现其在肺癌中的癌转移抑制作用。
Objective To investigate the role of nm23 gene expression in human lung cancer. Methods Northern blot hybridization was used to detect the expression of nm23H1 and nm23H2 mRNA in 40 cases of lung cancer and 19 cases of noncancer lung tissues. The signals were detected by digoxigenin labeling and detection system, and the mRNA expression and clinical features of lung cancer were analyzed. relationship. Results The expression of nm23H2 mRNA in poorly differentiated squamous cell carcinoma was significantly lower than that in moderately well differentiated squamous carcinoma (P<0.01). The expression of nm23H1 and nm23H2 mRNA in small cell lung cancer was significantly lower than that in lung squamous cell carcinoma. However, there was no significant difference in mRNA expression of nm23 in the primary tumor tissues with or without lymph node metastases and during the clinical course of lung cancer (P>0.05). Conclusions The mRNA expression of nm23 gene is related to the differentiation of lung cancer, and its metastasis suppressing effect in lung cancer was not found.